IndiaTickerTitan Biotech Ltd - 524717 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Titan Biotech
BSE:TITANBIO · ISIN INE150C01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Titan Biotech
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Titan Biotech Ltd - 524717 - Result_Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Titan Biotech Ltd - 524717 - Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May, 2026BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Corporate Action-Board to consider DividendBSE · corporate action · pdf
Source filing Titan Biotech Ltd - 524717 - Re-Appointment Of Cost Auditor For Financial Year 2026-2027BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial Year 2025-26.BSE · financial results · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Intimation Regarding Second 100 Days Campaign - 'Saksham Niveshak'BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Intimation Of Credit Confirmation Of Equity Shares From Depositories With Regard To Sub-Division / Split Of Equity Shares Of The Company BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Re-Lodgement Of Transfer Requests Of Physical SharesBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Titan Biotech Ltd - 524717 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2025BSE · financial results · pdf
Source filing Titan Biotech Ltd - 524717 - Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2025BSE · financial results · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement Regarding New ISIN Activation Letter From Depositories For Sub-Division Of Equity Share Of The CompanyBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - SEBI Circular Dated 30Th January 2026 On Ease Of Doing Investment - Special Window For Transfer And Dematerialisation Of Physical Securities
Special Window For Transfer And Dematerialisation Of Physical SecuritiesBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December, 2025.BSE · financial results · pdf
Source filing Titan Biotech Ltd - 524717 - Newspaper Advertisement Pertaining To Transfer Of Physical Shares Under Special WindowBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Re-Lodgement Of Transfer Requests Of Physical SharesBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Composition Of Committees Of The BoardBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Intimation Of Record Date For Sub Division / Split Of Equity Shares Of The CompanyBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Disclosure Under Regulation 7 Of SEBI (Prevention Of Insider Trading ) RegulationsBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th November, 2025
BSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationBSE · exchange filing · pdf
Source filing Titan Biotech Ltd - 524717 - Corporate Action-Intimation of Sub division / Stock SplitBSE · corporate action · pdf
Source filing